<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04075851</url>
  </required_header>
  <id_info>
    <org_study_id>20190801</org_study_id>
    <nct_id>NCT04075851</nct_id>
  </id_info>
  <brief_title>The Prevalence of Serum Thyroid Hormone Autoantibodies in Autoimmune Thyroid Diseases</brief_title>
  <official_title>The Prevalence of Serum Thyroid Hormone Autoantibodies in Autoimmune Thyroid Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shandong Provincial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shandong Provincial Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Thyroid hormone autoantibodies(THAA) in serum can Interfere radioimmunoassay for the
      determination of free thyroid hormones. Thyroid function test plays a key role in the
      diagnosis and treatment of autoimmune thyroid disease (AITD), and abnormal examination
      results in misdiagnosis and mistreatment. At present, the epidemiological results of THAA in
      AITD are inconsistent, and the pathogenesis has not been clarified. However, there is no
      relevant research on THAA in China. This project intends to collect AITD patients and healthy
      people, detecting THAA, at the same time testing thyroid function and thyroid autoantibodies,
      definiting positive rate of THAA in AITD patients, observing the effect of common therapeutic
      drugs for AITD on THAA, investigating the rule of THAA influencing thyroid function test
      results .This project will provide the basis and method for how to effectively avoid THAA
      interfering with thyroid function test.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2019</start_date>
  <completion_date type="Anticipated">August 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>prevalence of thyroid hormone autoantibodies in AITD</measure>
    <time_frame>measured after 1 year of follow-up</time_frame>
    <description>Radioimmuno precipitation test used for thyroid hormone autoantibodies</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Autoimmune Thyroid Disease</condition>
  <arm_group>
    <arm_group_label>Hashimoto or Grave's disease patients in treatment</arm_group_label>
    <description>Draw 10 ml venous blood</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hashimoto or Grave's disease patients on initial treatment</arm_group_label>
    <description>10 ml of venous blood was extracted every month for three months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pregnant woman with Hashimoto or Grave's disease</arm_group_label>
    <description>10 ml venous blood was extracted every month to postpartum for 6 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy crowd</arm_group_label>
    <description>Draw 10 ml venous blood</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Autoimmune thyroid diseases in endocrine outpatient department of shandong
        provincial hospital from August 1, 2019 to August 1, 2022
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  male or female with Hashimoto thyroiditis or Grave's disease aged for 18 to 65 years
             old

        Exclusion Criteria:

          -  Had a thyroidectomy Had a thyroid fine needle puncture biopsy Autoimmune diseases Take
             drugs that affect the immune system
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Haiqing Zhang</last_name>
    <role>Study Chair</role>
    <affiliation>shandong province hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ling Gao</last_name>
    <phone>+86 53168776910</phone>
    <email>gaoling1@medmall.com.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Shandong Province Hospital</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <zip>250021</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Haiqing Zhang</last_name>
      <phone>86-53-68776094</phone>
      <email>15168888303@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 29, 2019</study_first_submitted>
  <study_first_submitted_qc>August 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 3, 2019</study_first_posted>
  <last_update_submitted>August 29, 2019</last_update_submitted>
  <last_update_submitted_qc>August 29, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 3, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shandong Provincial Hospital</investigator_affiliation>
    <investigator_full_name>Hai-qing Zhang</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Autoimmune thyroid disease</keyword>
  <keyword>Thyroid hormone autoantibodies</keyword>
  <keyword>Hashimoto's thyroiditis</keyword>
  <keyword>Grave's disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thyroid Diseases</mesh_term>
    <mesh_term>Hashimoto Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

